Researchers have developed a new genetic screening tool that will aid in the investigation of possible treatments for patients with melanoma and the unique genetic mutations that may accompany the disease, according to data presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, held Nov. 12-16, 2011. Heinz-Herbert Fiebig, M.D., Ph.D., associate professor of medical oncology at the University of Freiburg in Germany, presented data from 25 patient-derived melanoma models for which he and his colleagues studied relevant genetic mutations and the effect of new targeted and cytotoxic chemotherapeutic agents.
Read more….
Nota sulle fonti / Source note — 18/10/2026: uno o più collegamenti storici non sono più disponibili all’indirizzo originale (HTTP 404); la citazione e il testo sono conservati. / One or more historical links are no longer available at their original address (HTTP 404); the citation and article text have been retained.